Communiqués de presse U.S. FDA Santé & sciences de la vie — Flux RSS et veille en direct
PPN World suit le flux RSS de U.S. FDA en temps réel — 8 communiqués indexés au cours des 30 derniers jours, le plus récent est arrivé il y a 4 j. Suivez-le avec alertes sur recherches enregistrées, résumés IA et recherche plein texte, ou branchez l'URL RSS ci-dessous dans votre propre lecteur.
À propos de ce fil
U.S. FDA fait partie des 1,400+ fils de presse que PPN World surveille en continu — un fil en anglais axé sur le secteur Santé & sciences de la vie, classé sous « États-Unis » dans notre index par pays. Chaque communiqué est dédupliqué, géolocalisé et enrichi d'un résumé IA, et vous pouvez y attacher des alertes sur recherches enregistrées. Au cours des 30 derniers jours, U.S. FDA a publié 8 communiqués, surtout le mercredi, avec une couverture récente centrée sur fda-approval.
Suivez U.S. FDA en temps réel dans PPN World
Chaque communiqué de U.S. FDA arrive dans le cockpit quelques secondes après sa publication — dédupliqué, classé, avec alertes sur recherches enregistrées et résumés IA, aux côtés de 1,400+ autres fils. Essai gratuit de 72 h, sans carte.
Commencer l'essai gratuit →Derniers communiqués de U.S. FDA
- FDA Approves First Therapy for Patients aged 8 years and older with Glycogen Storage Disease Type Iail y a 4 j
The U.S. Food and Drug Administration today issued an accelerated approval for Genglycos (pariglasgene brecaparvovec-opnr) as the first-ever treatment for adults and children 8 years of age and older…
- FDA Authorizes First-Of-Its-Kind Robotic Blood Draw Deviceil y a 4 j
The U.S. Food and Drug Administration today authorized the Aletta, the first standalone robotic device that can draw blood from a patient’s arm without hands-on operator intervention.
- FDA Seeks Public Feedback to Inform Regulatory Approach for Generative AI-Enabled Medical Devicesil y a 5 j
The U.S. Food and Drug Administration today issued a discussion paper on considerations for the regulation of generative artificial intelligence (GenAI)-enabled medical devices, seeking feedback from…
- FDA Issues Emergency Use Authorization for Drug to Treat New World Screwworm in Dogs and Puppiesil y a 10 j
The U.S. Food and Drug Administration today issued an Emergency Use Authorization (EUA) for Simparica TRIO (sarolaner, moxidectin, and pyrantel chewable tablets) for the treatment of New World screwwo…
- FDA Issues Emergency Use Authorization for Drug to Prevent New World Screwworm in Multiple Species, Including Sheep, Cattle, Goats, and Swineil y a 16 j
FDA today issued an Emergency Use Authorization (EUA) for CLiK Extra (dicyclanil topical suspension) wound spray for application on or around wounds for the prevention of New World screwworm (NWS) inf…
- FDA Approves New Engineered Viral Immunotherapy for Patients with Treatment-Resistant Advanced Melanomail y a 17 j
The U.S. Food and Drug Administration today granted accelerated approval to Tudriqev (vusolimogene oderparepvec-wtpg), a genetically modified oncolytic viral therapy for the treatment of advanced, ref…
- FDA Approves First Drug to Treat the Full Range of Narcolepsy Type 1 Symptomsil y a 18 j
The FDA approved Orzeyful (oveporexton) tablets for the treatment of narcolepsy type 1 in adults.
- FDA Licenses First-Ever Freeze-Dried Plasma Product in the U.S.il y a 25 j
FDA today licensed Ezplaz Freeze Dried Plasma (FDP), making it the first freeze-dried plasma product licensed for use in the United States. Ezplaz is intended for transfusion in adult patients who nee…
- FDA Announces First Participant Selected for TEMPO for Digital Health Devices Pilotil y a 32 j
The U.S. Food and Drug Administration today announced the first manufacturer selected for the Technology-Enabled Meaningful Patient Outcomes (TEMPO) for Digital Health Devices Pilot.
- FDA Takes Further Steps to Remove Outdated Authorizations for Color Additives in Foodil y a 32 j
The U.S. Food and Drug Administration today announced two actions targeting petroleum-based color additives in food, continuing the agency’s broader efforts to Make America Healthy Again.
- FDA Approves First Oral PCSK9 Inhibitor to Lower LDL Cholesterol in Adults with High Cholesterolil y a 37 j
The U.S. Food and Drug Administration approved Lipfendra (enlicitide), the first oral inhibitor of proprotein convertase subtilisin/kexin type 9 (PCSK9), as an adjunct to diet and exercise to reduce l…
- FDA Issues Emergency Use Authorization for Drug for Short-Term Prevention of New World Screwworm in Horsesil y a 39 j
The FDA today issued an Emergency Use Authorization (EUA) for Ivermectin Liquid for Horses (ivermectin oral solution) for the short-term prevention of New World screwworm (NWS) infestations (myiasis)…
Les plus récents communiqués de ce fil défilent en direct pour les membres PPN World.
Questions fréquentes
Comment suivre les communiqués de U.S. FDA en temps réel?+
À quelle fréquence les communiqués de U.S. FDA sont-ils relevés?+
Quel type de communiqués U.S. FDA publie-t-il?+
Fils liés
- PR Newswire (US) — Health
- Newswise — Science News (US)
- U.S. CDC
- 24-7 Press Release — Industry: Biotechnology
- 24-7 Press Release — Industry: Healthcare
- 24-7 Press Release — Industry: Health & Fitness
- 24-7 Press Release — Medical: Addiction
- 24-7 Press Release — Medical: Aids
- 24-7 Press Release — Medical: Allergies
- 24-7 Press Release — Medical: Alternative Medicine